GlassScriptPhysician profile
Jennifer Lavigne
NPI 1568931673
$6,183.25
in general payments reported to CMS, 2019-2025
54 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $2,322 · 2023: $1,795 · 2024: $1,298 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,288 · Education: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,288.46 |
| Education | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $525.93 | 2022-2025 | Calquence, Enhertu, Lynparza |
| Merck Sharp & Dohme LLC | $457.38 | 2022-2024 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $404.44 | 2022-2025 | |
| Seagen INC. | $397.65 | 2022-2024 | Tukysa, Adcetris, Tivdak |
| Ipsen Biopharmaceuticals, INC | $325.08 | 2022-2024 | Tazverik, Onivyde |
| Pharmacyclics LLC, An Abbvie Company | $285.04 | 2022-2023 | Imbruvica |
| Glaxosmithkline, LLC. | $269.77 | 2021-2024 | Jemperli, Zejula |
| Daiichi Sankyo INC. | $224.25 | 2022-2024 | Enhertu, Injectafer |
| Amgen INC. | $208.75 | 2021 | |
| Gilead Sciences, INC. | $199.15 | 2021-2024 | Trodelvy |
| Pfizer INC. | $198.13 | 2022-2024 | |
| Genentech USA, INC. | $179.19 | 2022-2025 | Venclexta, Columvi, Lunsumio |
| Incyte Corporation | $176.22 | 2022-2024 | Jakafi |
| Genzyme Corporation | $156.27 | 2022-2023 | |
| Sirtex Medical INC | $139.38 | 2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $139.03 | 2023-2024 | |
| Astellas Pharma US INC | $136.92 | 2023-2025 | Xospata, Padcev |
| Eisai INC. | $133.42 | 2022-2024 | |
| Emd Serono, INC. | $128.49 | 2022-2024 | Bavencio |
| Janssen Biotech, INC. | $122.97 | 2022-2024 | Tecvayli, Talvey, Akeega |
| Adc Therapeutics America, INC. | $120.46 | 2022 | |
| Exelixis INC. | $112.71 | 2023-2024 | Cabometyx |
| Lilly USA, LLC | $112.09 | 2023-2024 | Jaypirca, Verzenio, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $105.83 | 2022-2023 | Fruzaqla |
| Karyopharm Therapeutics INC. | $87.61 | 2022-2024 | Xpovio |
| Tersera Therapeutics LLC | $67.03 | 2022-2025 | Xermelo, Zoladex |
| Bayer Healthcare Pharmaceuticals INC. | $54.94 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $49.02 | 2022-2023 | Libtayo |
| Kyowa Kirin, INC. | $45.19 | 2022-2023 | Poteligeo |
| Servier Pharmaceuticals LLC | $42.44 | 2023-2024 | |
| Sobi, INC | $41.83 | 2022-2023 | |
| Caris Mpi, INC. | $39.91 | 2025 | Mi Cancer Seek |
| Jazz Pharmaceuticals INC. | $39.72 | 2022 | |
| Stemline Therapeutics INC. | $35.58 | 2023-2024 | Orserdu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.78 | 2023 | Gilotrif |
| Acrotech Biopharma INC. | $33.65 | 2022-2024 | Beleodaq |
| Taiho Oncology, INC. | $30.91 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $30.54 | 2023 | Orgovyx |
| Coherus Oncology, INC. | $27.58 | 2023 | |
| Progenics Pharmaceuticals, INC. | $24.50 | 2023 | Pylarify |
| Sun Pharmaceutical Industries INC. | $23.90 | 2023 | Yonsa |
| Alexion Pharmaceuticals, INC. | $23.84 | 2023 | Ultomiris |
| G1 Therapeutics, INC. | $23.46 | 2023 | Cosela |
| Deciphera Pharmaceuticals INC. | $17.75 | 2024 | Qinlock |
| Spectrum Pharmaceuticals INC. | $17.62 | 2023 | Rolvedon |
| Genmab U.S., INC. | $16.98 | 2023 | Epkinly |
| Pharmacosmos Therapeutics INC. | $16.54 | 2024 | Monoferric |
| Pharmaessentia USA Corporation | $16.18 | 2024 | Besremi |
| Foundation Medicine, INC. | $16.18 | 2023 | Foundationone Cdx |
| Celgene Corporation | $15.56 | 2022 | |
| Mirati Therapeutics, INC. | $14.38 | 2023 | Krazati |
| Myovant Sciences INC. | $14.22 | 2022 | |
| Agios Pharmaceuticals, INC. | $12.49 | 2022 | |
| Rigel Pharmaceuticals, INC. | $10.37 | 2023 | Rezlidhia, Tavalisse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lavigne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.